Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Buying intensifies in second half
Wed, 23 Sep Closing

Buying activity intensified as the day progressed, leading the markets to end the day on a firm note. The BSE-Sensex closed higher by about 171 points, while the NSE-Nifty ended higher by about 34 points. Stocks across the board were trading strong with consumer durables and banking stocks leading the pack of gainers. Mid and smallcap stocks ended the day on a positive note as well, with the BSE Mid Cap and BSE Small Cap indices closing higher by about 0.5% and 0.7% respectively

Asian markets finished sharply lower today with shares in Hong Kong being the worst performer. The Hang Seng was down 2.28% while China's Shanghai Composite was off by 2.19%. Japan's Nikkei 225 ended lower by 1.96%. European markets are sharply higher today with shares in London leading the region. The FTSE 100 is up 1.32% while Germany's DAX is up 1.06% and France's CAC 40 is up 1.01%. The rupee was trading weak at 65.98 against the US$ in the afternoon session.

Power stocks ended the trading day with moderate gains with Jaiprakash Power and Torrent Power leading the gains. Shares of state owned NTPC surged after it was reported that the company is all set to start production from nine coal mines allocated in a phased manner over the next two to three years. Of the nine mines, Pakri-Barwadih is in an advanced stage and the company has target to begin production from this mine this year. NTPC was amongst the companies which had a few coal mines de-allocated after the Supreme Court's ruling last September. However, in March, the company was reallocated five of its cancelled coal mines under the new regime as well as got four more mines. NTPC is the largest power generating company in the country.

As per a leading financial daily, Pfizer has entered into a business transfer agreement for transfer of its business at Thane plant as a going concern to Vidhi Research and Development LLP. The consideration for this plant sell-off was decided at Rs 1.78 bn. Further, the company is starting 20 clinical trials this year and more soon after on treatments to conquer cancer in order to gain leadership in one of the most lucrative areas of medicine. Presently, Pfizer has eight approved cancer medicines, four of them launched in the last four years.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Buying intensifies in second half". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.